Hans Kaspar Binz

USPTO Granted Patents = 17 (Patent Applications = 3)

CIPO Patents = 6

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 123(Granted Patents)

Location History:

Zürich, CH (2008)
Birmensdorf, CH (2014 - 2022)
Zurich-Schlieren, CH (2023)

Company Filing History:

14 out of 22

Molecular Partners Ag

Years Active: 2008-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435445 - Designed ankyrin repeat domains with altered surface residues (2025-10-07),

2. 11578427 - Designed ankyrin repeat domains with altered surface residues (2023-02-14),

3. 11332501 - Recombinant binding proteins and their use (2022-05-17),

4. 10646542 - Modified binding proteins inhibiting the VEGF-A receptor interaction (2020-05-12),

5. 10322190 - Capping modules for designed ankyrin repeat proteins (2019-06-18),

6. 10155791 - Recombinant binding proteins and their use (2018-12-18),

7. 9849158 - Modified binding proteins inhibiting the VEGF-A receptor interaction (2017-12-26),

8. 9775912 - Designed repeat proteins binding to serum albumin (2017-10-03),

9. 9717802 - Capping modules for designed ankyrin repeat proteins (2017-08-01),

10. 9657287 - Repeat protein from collection of repeat proteins comprising repeat modules (2017-05-23),

11. 9458211 - Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains (2016-10-04),

12. 9289466 - Modified binding proteins inhibiting the VEGF-A receptor interaction (2016-03-22),

13. 9284361 - Designed repeat proteins binding to serum albumin (2016-03-15),

14. 9221892 - Capping modules for designed ankyrin repeat proteins (2015-12-29),

15. 9006389 - Repeat protein from collection of repeat proteins comprising repeat modules (2015-04-14),

Title: Innovations of Hans Kaspar Binz in Biomedicine

Introduction

Hans Kaspar Binz, an accomplished inventor based in Birmensdorf, Switzerland, has made significant contributions to the field of biomedicine through his innovative work. With a remarkable portfolio comprising 16 patents, his research has led to valuable advancements in therapeutic applications.

Latest Patents

Among his latest inventions are two notable patents that focus on designed ankyrin repeat domains. The first patent discusses designed ankyrin repeat domains with altered surface residues. This invention includes proteins formed with these designed domains, nucleic acids encoding them, and methods for their preparation. The potential applications of these proteins, nucleic acids, or pharmaceutical compositions are centered around the treatment of diseases.

The second patent elaborates on recombinant binding proteins, emphasizing their specificity for serum albumin as well as hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF-A). This invention also includes nucleic acids encoding the designed ankyrin repeat domains and their use in medical treatments, showcasing Binz's commitment to addressing critical health issues through innovative solutions.

Career Highlights

Throughout his career, Hans Kaspar Binz has worked with prominent organizations, including Molecular Partners AG and the University of Zurich. His experience in these institutions has allowed him to refine his expertise and drive his research towards practical applications in the biomedical field.

Collaborations

In his journey as an inventor, Binz has collaborated with notable colleagues such as Michael Tobias Stumpp and Patrik Forrer. These partnerships have likely enriched his research perspectives and contributed to the success of his innovative projects.

Conclusion

Hans Kaspar Binz stands out as a beacon of innovation in biomedicine. His 16 patents highlight his dedication to developing novel solutions for treating various diseases. With a solid foundation in research and collaboration, Binz's work continues to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.